- Full Year 2024 Eisai Co Ltd Earnings Presentation TranscriptMay 15, 2024
- Eisai Co Ltd Information Meeting TranscriptMar 08, 2024
- Q3 2024 Eisai Co Ltd Earnings Presentation TranscriptFeb 06, 2024
- Eisai Co Ltd Launch of LEQEMBI in Japan TranscriptDec 13, 2023
- Q2 2024 Eisai Co Ltd Earnings Presentation TranscriptNov 07, 2023
- Q1 2024 Eisai Co Ltd Earnings Presentation TranscriptAug 02, 2023
- Eisai Co Ltd Media and Investor Conference TranscriptJul 07, 2023
- Full Year 2023 Eisai Co Ltd Earnings Presentation TranscriptMay 15, 2023
- Eisai Co Ltd Information Meeting TranscriptMar 10, 2023
- Q3 2023 Eisai Co Ltd Earnings Call TranscriptFeb 06, 2023$61.5Earnings
- Eisai Co Ltd Approach to US Pricing for LEQEMBI Briefing TranscriptJan 07, 2023
- Eisai Co Ltd Clarity AD Study Briefing TranscriptNov 30, 2022
- Q2 2023 Eisai Co Ltd Earnings Call TranscriptNov 07, 2022$58.36Earnings
- Eisai Co Ltd Lecanemab Phase 3 Study Met Primary Endpoint Call TranscriptSep 28, 2022
- Q1 2023 Eisai Co Ltd Earnings Call TranscriptAug 05, 2022$46.1Earnings
- Full Year 2022 Eisai Co Ltd Earnings Presentation TranscriptMay 13, 2022
- Eisai Co Ltd Information Meeting TranscriptMar 16, 2022
- Q3 2022 Eisai Co Ltd Earnings Call TranscriptFeb 03, 2022$52.14Earnings
- Q2 2022 Eisai Co Ltd Earnings Call TranscriptNov 01, 2021$70.2Earnings
- Q1 2022 Eisai Co Ltd Earnings Call TranscriptAug 04, 2021$93.97Earnings
- Eisai Co Ltd FDA Grants Accelerated Approval for ADUHELM Presentation TranscriptJun 09, 2021
- Full Year 2021 Eisai Co Ltd Earnings Call TranscriptMay 12, 2021$71.51Earnings
- Eisai Co Ltd Information Meeting TranscriptMar 26, 2021
- Q3 2021 Eisai Co Ltd Earnings Call TranscriptFeb 03, 2021$71.88 (-2.86%)Earnings
- Q2 2021 Eisai Co Ltd Earnings Call TranscriptNov 05, 2020$74.75Earnings
- Q1 2021 Eisai Co Ltd Earnings Call TranscriptAug 03, 2020$80.01Earnings
- Full Year 2020 Eisai Co Ltd Earnings Call TranscriptMay 13, 2020$62 (-17.88%)Earnings
- Eisai Co Ltd Information Meeting TranscriptMar 06, 2020
- Q3 2020 Eisai Co Ltd Earnings Presentation and Conference Call TranscriptJan 31, 2020
- Full Year 2019 Eisai Co Ltd Earnings Presentation and Conference Call TranscriptMay 13, 2019
- Eisai Co Ltd Information Meeting TranscriptMar 08, 2019
Q1 2023 Eisai Co Ltd Earnings Call Transcript
Now it's time to start the financial results briefing session for the first quarter of FY 2022 of Eisai Company Limited. Thank you very much for your participation despite of busy schedule. For this meeting here today in the beginning we considered to have this as the venue and online base hybrid presentation meeting. But due to the COVID-19 pandemic situation recently we decided to have the live streaming and telephone line online type of the meeting. I believe some of you are here through the telephone line. In that case please come to our website so that you can find our presentation material. So today's presentation finance part is going to be given by the CFO, Chief IR Officer, Tatsuyuki Yasuno, Neurology Part Global Area Officer, Ivan Cheung. For Oncology Part, Chief Scientific Officer, Takashi Owa. Those are the presenters for today. And when it comes to the presentation by Ivan Cheung is going to be given in English. So with regards to Japanese, you can listen to the simultaneous translation. Thank you very much. Now getting into the presentation.
First of all
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)